SOURCE: Eurand N.V.

Eurand N.V.

January 27, 2010 13:18 ET

Eurand to Present at Deutsche Bank Securities Small- and Mid-Cap Conference

PHILADELPHIA, PA--(Marketwire - January 27, 2010) - Eurand N.V. (NASDAQ: EURX), a global specialty pharmaceutical company, announced today that it is scheduled to present at the upcoming Deutsche Bank Securities Small- and Mid-Cap Conference. Presenting will be Bill Newbould, Eurand's Vice President, Investor Relations.

Event:      Deutsche Bank Securities Small- and Mid-Cap Conference
Date:       Tuesday, February 9, 2010
Time:       2:00 p.m. ET
Location:   The Ritz-Carlton, Naples, Fla.

An audio webcast of the presentation will be available by accessing the investor relations section of Eurand's web site at www.eurand.com. A replay of the presentation will be available until March 9, 2010.

About Eurand

Eurand is a specialty pharmaceutical company that develops, manufactures and commercializes enhanced pharmaceutical and biopharmaceutical products based on its proprietary pharmaceutical technologies. Eurand has had six products approved by the FDA since 2001 and has a pipeline of product candidates in development for itself and its collaboration partners. Its technology platforms include bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking orally disintegrating tablet (ODT) formulations, and drug conjugation.

Eurand is a global company with facilities in the U.S. and Europe. For more information, visit Eurand's website at www.eurand.com.

Contact Information